MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$592.02
−0.23%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
32.2x
EV/EBITDA
26.8x
Market Cap
$16.52B
MomentumView details →
1D Return
−0.23%
YTD Return
+4.61%
RSI (14)
49.0
ValuationView details →
P/E (Fwd)
32.2x
EV/EBITDA
26.8x
Market Cap
$16.52B
RSI (14)
49.0
MomentumView details →
1D Return
−0.23%
YTD Return
+4.61%
SummaryUpdated Jun 1, 2026
Medpace Holdings, Inc. (NASDAQ:MEDP) is a Cincinnati-based contract research organization (CRO) founded in 1992 that provides clinical trial services to pharmaceutical, biotechnology, and medical device companies. The company went public in August 2016 and has established itself as a specialized CRO focused primarily on serving biotech clients through the complete clinical development process from Phase I through Phase IV trials across various therapeutic areas.
Similar companies
Latest newsMore news →
Medpace reported second-quarter earnings that beat expectations.9d agoAllworth Financial LP acquired a new stake in Medpace Holdings, Inc. during the second quarter of 2026, purchasing 3,894 shares valued at approximately $2,062,000, as disclosed in a 13F filing.13d agoAbacus FCF Advisors LLC acquired a new stake in Medpace Holdings, Inc. during the second quarter, purchasing 12,529 shares valued at approximately $6.63 million.15d ago